Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 870

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 870
---
 continuous service with respect to restricted stock for any shares that are issued and unvested.

In December 2022, the 2020 Plan expired and 182,000 stock options and 2,000 RSUs granted prior to the 2020 Plan expiration remain outstanding as of September 30, 2024.

2022 Equity Incentive Plan

In December 2022, the Company approved the 2022 Equity Incentive Plan (the “2022 Plan”). The 2022 Plan provides for the grant of incentive stock option, non-statutory stock options, restricted stock, restricted stock units, stock appreciation rights (“SARs”), performance units and performance shares to employees, directors and independent contractors of the Company. Under the 2022 Plan, the exercise price of stock options grants shall be at 100% fair market value of the Company’s common stock on the date of grant and the contractual term of stock options granted shall not exceed ten years. Options become vested and, if applicable, exercisable based on terms determined by the Company’s board of directors or other plan administrator on the date of grant, which is continued employment or service as defined in each option agreement. SARs provide a participant with the right to receive the aggregate appreciation in stock price over the market price of the Company’s common stock at the date of grant, payable in cash or in shares of equivalent value.**

<div align='center'>F-137</div>

Stock Option Activity The following table summarizes stock option activity under the Company’s equity incentive plans:

|                                      |     | Outstanding                                        
 Stock                                              
 Options                                            
 (in thousands, except per share amounts and years) |       |   |     | Weighted- 
 Average   
 Exercise  
 Price Per 
 Share     |       |     | Weighted-   
 Average     
 Remaining   
 Contractual 
 Term        
 (years)     |     |     | Aggregate 
 Intrinsic 
 Value     |     |
|:-------------------------------------|:----|:---------------------------------------------------|------:|:--|:----|:----------|------:|:----|:------------|----:|:----|:----------|----:|
| December 31, 2023                    |     |                                                    | 1,975 |   |     | $         |  9.00 |     |             | 7.6 |     | $         | 604 |
| Granted                              |     |                                                    | 1,028 |   |     | $         |  0.38